Raysearch Laboratories (RAY-B.ST) traded down -0.98 % during a 24 hours period ending at 10:34 PM Central Europe on Monday 26th. One Raysearch Laboratories stock can currently be bought for about SEK 192.7 on popular exchanges. Current supply of Raysearch Laboratories stocks is 29.8 mn. Raysearch Laboratories has a current market capitalization of SEK 5.7 bn and approximately SEK 14.2 mn worth of Raysearch Laboratories was traded on exchanges in the last 24 hours. Since last month end, Raysearch Laboratories has traded 13.95 % up. Simple moving average of last 200 days is at SEK 194.61. The highest price of past 52 weeks was recorded at SEK 264.5 on 11/07/2025. 52 weeks low was at SEK 153.1 on 07/16/2026.

Here is how related stocks have performed in the past 24 hours:

  • Momentum Komponenter & (MMGR-B.ST) traded up 0.96 % and now trades at SEK 128. Current market capitalisation for Momentum Komponenter & is SEK 6.2 bn. Current price/earnings ratio for Momentum Komponenter & is 31.69. Momentum Group Registered B released its financial results for the quarter ended 30 September 2026 on 23 October. The company reported a positive earnings per share, improving on the previous quarter’s figure, and noted a growth in revenue of roughly eight percent compared to the same period a year earlier. Total sales were reported at just over 800 million Swedish krona, up from about 750 million in the prior year. The announcement came without additional commentary on strategic initiatives or market outlook. The data were sourced from a standard earnings release, and no further context was provided regarding the company’s broader financial performance or future guidance.

  • Xvivo Perfusion (XVIVO.ST) traded down -7.79 % and now trades at SEK 202.2. Current market capitalisation for Xvivo Perfusion is SEK 6.5 bn. Xvivo Perfusion has a current price to earnings ratio of 50.56.

  • Bahnhof -B (BAHN-B.ST) traded flat 0 % and now trades at SEK 59.8. Bahnhof -B has a market capitalisation of SEK 6.4 bn. Bahnhof -B has a current price to earnings ratio of 34.48.

  • Sivers Semiconductors (SIVE.ST) traded down -3.91 % and now trades at SEK 21.04. Current market capitalisation for Sivers Semiconductors is SEK 6.6 bn.

  • Acast (ACAST.ST) traded down -0.77 % and now trades at SEK 32. Acast has a market capitalisation of SEK 5.9 bn. Acast has a current price to earnings ratio of 63.84.

About Raysearch Laboratories

RaySearch Laboratories AB is a medical technology company that specializes in developing software solutions for cancer treatment in North America, Asia, Europe, and internationally. The company’s primary product is RayStation, a treatment planning system designed for radiation therapy centers to facilitate various treatment activities such as automated planning, adaptive therapy, multi-criteria and speed and advanced optimization, physician’s toolbox, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, and stereotactic planning, proton therapy, and carbon ion therapy. Additionally, RaySearch Laboratories AB develops RayPlan, a solution for supporting a range of treatment planning activities; and RayCare, a machine learning oncology information system for the treatment of cancer. Training courses and customer support services are also provided by the company. Established in 2000 with its headquarter located in Stockholm, Sweden, RaySearch Laboratories AB has strategic alliances with various organizations to advance adaptive radiation therapy in cancer treatment.